Search results
2 days ago · The Oxford–AstraZeneca COVID‑19 vaccine is used to provide protection against infection by the SARS-CoV-2 virus in order to prevent COVID-19 in adults aged 18 years and older. The medicine is administered by two 0.5 ml (0.017 US fl oz) doses given by intramuscular injection into the deltoid muscle (upper arm).
- AU: B1
- SARS-CoV-2
- Vaxzevria, Covishield
- Viral vector
4 days ago · Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition that has become the central focus of a class-action lawsuit worth potentially $125 million. A Northeastern University legal scholar says the admission isn’t especially damning, as the rare condition ...
3 days ago · This story is republished courtesy of Northeastern Global News news.northeastern.edu. Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but ...
4 days ago · Pharmaceutical giant AstraZeneca has admitted that its widely used Covid vaccine, branded Covishield, can cause rare side effects including blood clots and low platelet count.. Covishield was ...
3 days ago · Yesterday, AstraZeneca, a prominent Covid-19 vaccine manufacturer that was administered to millions of people around the world, specifically most in India, admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria, among others, may lead to a rare, deadly side effect ...
4 days ago · AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. According to media reports, the admission was made in a legal document submitted to the UK High Court in February.
4 days ago · In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects. The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, caused death and serious injury, including TTS. By: Express Web Desk.
